A Dose Ranging Study to Compare the Safety and Efficacy of Aliskiren 150mg, 300mg, and 600mg to Placebo in Patients With High Blood Pressure.

NCT00219128 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
671
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis